News

Investors with substantial losses have the opportunity (until August 25, 2025) to move the court for appointment as Lead Plaintiff. Shareholder rights firm Hagens Berman is investigating the legal ...
Novo Nordisk (NVO) announced that the US Food and Drug Administration has approved an additional indication for Wegovy based ...